Immunotherapy-mediated dermatological adverse events: the urgent need for a common, clinically meaningful, management strategy

Support Care Cancer. 2020 Dec;28(12):5597-5599. doi: 10.1007/s00520-020-05701-9. Epub 2020 Aug 21.

Authors

Zoe Apalla¹, Vincent Sibaud²

Affiliations

¹ Second Dermatology Department, Aristotle University of Thessaloniki, Thessaloniki, Greece. zoimd@yahoo.gr.
² Oncodermatology Department, Cancer University Institute, Toulouse Oncopole, Toulouse, France.

PMID: 32827054
DOI: 10.1007/s00520-020-05701-9

No abstract available

Keywords: Adverse events; Immune checkpoint inhibitors; Immunotherapy; Management; Skin toxicity.